MDxHealth SA Reports Preliminary Q2 2024 Revenue of $22.2M

Ticker: MDXH · Form: 6-K · Filed: Jul 8, 2024 · CIK: 1872529

Mdxhealth SA 6-K Filing Summary
FieldDetail
CompanyMdxhealth SA (MDXH)
Form Type6-K
Filed DateJul 8, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$22.2, $42.0 m, $21.3 million
Sentimentneutral

Sentiment: neutral

Topics: revenue-update, preliminary-results, financials

TL;DR

MDxHealth SA posts preliminary $22.2M Q2 revenue, $42.0M H1 revenue, and $21.3M cash on hand as of June 30.

AI Summary

MDxHealth SA reported preliminary Q2 2024 revenues of approximately $22.2 million and first half 2024 revenues of $42.0 million on July 8, 2024. The company's cash balance as of June 30, 2024, stood at $21.3 million. These results are preliminary as the company has not yet completed its quarterly financial statements.

Why It Matters

This filing provides investors with an early look at MDxHealth's financial performance for the second quarter and first half of 2024, including key revenue figures and cash position.

Risk Assessment

Risk Level: medium — The preliminary nature of the results and the fact that the company has not completed its quarterly financial statements introduce uncertainty.

Key Numbers

Key Players & Entities

FAQ

What are the preliminary revenue figures for MDxHealth SA's second quarter and first half of 2024?

MDxHealth SA reported preliminary revenues of approximately $22.2 million for the second quarter and $42.0 million for the first half of 2024.

What was MDxHealth SA's cash balance as of June 30, 2024?

The company's cash balance as of June 30, 2024, was $21.3 million.

When did MDxHealth SA file this report?

This report was filed on July 8, 2024.

Are the reported financial results for MDxHealth SA final?

No, the reported results are preliminary, and the company has not completed its quarterly financial statements.

What is the principal executive office address for MDxHealth SA?

The principal executive office is located at CAP Business Center, Zone Industrielle des Hauts-Sarts, 4040 Herstal, Belgium.

Filing Stats: 511 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-07-08 16:05:02

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MDXHEALTH SA Date: July 8, 2024 By: /s/ Michael McGarrity Name: Michael McGarrity Title: Chief Executive Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing